Cowen analyst Joesph Thome initiated coverage of Xenon Pharmaceuticals with an Outperform rating.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on XENE:
- Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
- Xenon Pharmaceuticals provides updates on neurology programs at AES 2022
- Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
- Xenon Pharmaceuticals initiated with an Overweight at Wells Fargo
- Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences